Recent Publications on : |  |
A Novel Bacillus Calmette-Guerin-based Breast Cancer Vaccine that Coexpresses Multiple Tandem Repeats of MUC1 and CD80 Breaks the Immune Tolerance and Inhibits MUC1-Positive Breast Cancer Growth.
Abstract Many approaches targeting MUC1 for breast tumor immunotherapy... Direct Link | 3rd November, 2009
| 1 Department of Vascular and Endocrine Surgery, Xijing Hospital, Fourth
|
| Tumor burden influences cytotoxic T cell development in metastatic breast cancer patients--a phase I/II study.
| 29th October, 2009
| Medical Service, Amarillo Veterans Affairs Health Care System, Amarillo,
|
Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology.
Malignant ascites may be the first presentation of an unsuspected cancer.... Direct Link | 27th October, 2009
| Department of Pathology, Wayne State University and Karmanos Cancer
|
Functional Neoglycopeptides: Synthesis and Characterization of a New Class of MUC1 Glycoprotein Models Having Core 2-Based O-Glycan and Complex-Type N-Glycan Chains.
An efficient protocol for the construction of MUC1-related glycopeptide... Direct Link | 27th October, 2009
| Division of Advanced Chemical Biology, Graduate School of Life Science,
|
Intratumoral cytokines and tumor cell biology determine spontaneous breast cancer-specific immune responses and their correlation to prognosis.
Spontaneous immune responses in cancer patients have been described. Yet... Direct Link | 22nd October, 2009
| Department of Obstetrics and Gynecology, University Hospital of
|
A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells.
Endometriosis is defined by the presence of tissue implants resembling... Direct Link | 21st October, 2009
| Department of Obstetrics, Gynecology and Reproductive Sciences, University
|
Can strategies targeting cleaved MUC1 overcome resistance to trastuzumab?
Endometriosis is defined by the presence of tissue implants resembling... Direct Link | 17th October, 2009
| Braman Family Breast Cancer Research Institute, University of Miami
|
The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers.
The membrane-bound mucins belong to an ever-increasing family of... Direct Link | 13th October, 2009
| Inserm, U837, Jean-Pierre Aubert Research Centre, Team 5 "Mucins,
|
MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy.
The bacterium Helicobacter pylori can cause peptic ulcer disease, gastric... Direct Link | 10th October, 2009
| Mucosal Diseases Program, Mater Medical Research Institute, Mater Health
|
Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer.
ABSTRACT: INTRODUCTION: MUC1 is a cell surface glycoprotein that... Direct Link | 9th October, 2009
|
|
| An autologous therapeutic dendritic cell vaccine transfected with total lung carcinoma RNA stimulates cytotoxic T lymphocyte responses against non-small cell lung cancer.
| 9th October, 2009
| Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong
|
Tumor-Associated MUC1 Tandem-Repeat Glycopeptide Microarrays To Evaluate Serum- and Monoclonal-Antibody Specificity.
OBJECTIVE: The development of immunotherapy for malignancy is greatly... Direct Link | 2nd October, 2009
| Department of Chemical Biology, Max-Planck Institute of Molecular
|
Significance of mucin expression in pancreatobiliary neoplasms.
Mucins are high molecular weight glycoproteins that play important roles... Direct Link | 30th September, 2009
| Department of Human Pathology, Field of Oncology, Course of Advanced
|
Immunohistochemical study of mucin expression in periampullary adenomyoma.
BACKGROUND/PURPOSE: Benign tumors and tumor-like conditions in the... Direct Link | 29th September, 2009
| Department of Human Pathology, Field of Oncology, Kagoshima University
|
Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumor cells.
The MUC1 mucin is differentially expressed and glycosylated in cancer... Direct Link | 25th September, 2009
| Department of Immunotechnology, Lund University, Lund, Sweden.
|